Factors associated with persistent or recurrent primary hyperparathyroidism after surgical treatment: A population-based cohort study
In brief
Parathyroid surgery cured 90.5% of Ontario patients; only benchmark-volume surgeons topped 95%
Among 4,230 Ontario patients, about 9 in 10 achieved sustained normal calcium levels within a year of surgery. Older age, a single adenoma, and lower preoperative calcium were associated with lower odds of noncure; higher surgeon and hospital volumes and intraoperative hormone monitoring showed beneficial but nonsignificant trends. The findings point to expertise as a potential factor, but do not prove it improves outcomes.
- Journal
- Surgery (Q1)
- Published
- 6 November 2026
- Study design
- Retrospective cohort
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Florence Bénard, Rogeh Habashi, Jonas Shellenberger, Rebecca Griffiths, Paige McKinley, Alexia Mitsopoulos, et al.
- PMID
- 43057960
- DOI
- 10.1016/j.surg.2026.110820
Why clinicians should know about it
- Picked for Breast and Endocrine Surgery (paper of the day, 22 November 2026): Population-based outcomes after parathyroidectomy for primary hyperparathyroidism
Abstract
BACKGROUND: Parathyroidectomy is the only curative treatment for primary hyperparathyroidism. Low, persistent, or recurrent disease remains a concern and is associated with a lower likelihood of cure. High-volume centers report cure rates exceeding 95%, whereas population-based data examining factors associated with noncure are limited. We aimed to identify predictors of persistent or recurrent primary hyperparathyroidism following parathyroidectomy. METHODS: We conducted a population-based retrospective cohort study of 4,230 patients who underwent parathyroidectomy in Ontario between 2016 and 2019. Multivariable Poisson regression models estimated rate ratios for noncure, adjusting for patient, hospital, and surgeon characteristics. Variables included demographics, biochemical severity, and surgical factors. RESULTS: Overall, 3,829 patients (90.5%) achieved biochemical cure, defined as sustained normocalcemia within 1 year postoperatively. Older age (≥55 years) was associated with a lower risk of noncure (rate ratio, 0.78; P = .026). Sex, socioeconomic status, and comorbidity burden were not associated with outcomes. Patients with single adenomas had a lower recurrence risk (rate ratio, 0.48; P < .001). Intermediate preoperative calcium levels were associated with increased recurrence risk (rate ratio, 1.74; P < .001) compared with lower calcium levels, whereas preoperative parathyroid hormone was not predictive. Surgical factors showed clinically meaningful but nonsignificant trends: intraoperative parathyroid hormone monitoring was associated with approximately 50% lower failure risk; higher surgeon and hospital volumes correlated with improved outcomes. Only surgeons meeting American Association of Endocrine Surgeons volume benchmarks achieved cure rates ≥95%. CONCLUSION: Older age, single adenoma, and lower preoperative calcium levels were protective against noncure. Higher surgical volume and intraoperative parathyroid hormone monitoring appeared beneficial, underscoring the importance of specialized expertise and standardized intraoperative practices.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.